KEGG   DRUG: Labuvirtide
Entry
D13020                      Drug                                   
Name
Labuvirtide (INN);
Albuvirtide
Formula
C204H306N54O72
Exact mass
4664.1943
Mol weight
4666.93
Structure
Sequence
WEEWDREINN YTKLIHELIE ESQNQQEKNE QELL
  Type
Peptide
Class
Antiviral
 DG03107  Anti-HIV agent
Remark
ATC code: J05AX33
Efficacy
Antiviral, HIV-1 gp41 fusion inhibitor
  Type
Modified peptide
Target
HIV-1 gp41 [KO:K24801]
  Pathway
ko03230  Viral genome structure
ko03250  Viral life cycle - HIV-1
ko03260  Virion - Human immunodeficiency virus
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J05 ANTIVIRALS FOR SYSTEMIC USE
   J05A DIRECT ACTING ANTIVIRALS
    J05AX Other antivirals
     J05AX33 Labuvirtide
      D13020  Labuvirtide (INN)
Drug groups [BR:br08330]
 Antiviral
  DG03107  Anti-HIV agent
   D13020  Labuvirtide
Antimicrobials [BR:br08307]
 Antivirals
  Entry, fusion or uncoating inhibitor
   HIV gp41/gp120
    D13020  Labuvirtide (INN)
Other DBs
CAS: 2395796-76-4
PubChem: 505028117
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system